Publication|Videos|February 13, 2025
Implementing Diversity, Equity, and Inclusion in Drug Development
Jennifer Kim, PhD, assistant research professor, Tufts School of Medicine, Tufts Center for the Study of Drug Development, discusses barriers to participation for underrepresented populations in clinical trials and how Tufts is conducting research to better understand their nature.
Advertisement
Episodes in this series
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
2
Is Artificial Intelligence Coming for Clinical Research?
3
ACT Brief: AI in Clinical Research, FDA Gene Therapy Approval, and High-Performing Hospital Partnerships
4
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
